Tumor Ablation Market (Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, High-Intensity Focused Ultrasound, and Laser Interstitial Thermal Ablation; Disease Indication - Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, and Prostate Cancer; End Users - Hospitals and Cancer Specialty Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2014 - 2024
Global Tumor Ablation Market: Overview Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For tumor ablation procedure Ultrasound (US) or Magnetic Resonance Imaging (MRI), Computed Tomography (CT), is used to guide and position the needle probe into the tumor. A detailed overview of market dynamics, including the drivers, restraints, and opportunities of the tumor ablation market, has been provided in this report. Market revenue for all the above mentioned segments, and their sub segments has been provided for the forecast period of 2016-2024, considering 2015 as the base year, and 2014 as the historical year, along with compound annual growth rate (CAGR %), for the forecast period of 2016-2024. Market share estimations were based on in-depth analysis and study of products, and their features, prices etc.
This report provides in-depth analysis of the tumor ablation market. The stakeholders for this report include companies involved in the manufacturing of ablation devices and its spares parts. For providing a snapshot of this market to the stakeholders, executive summary section is included in this report, which summarizes the market size, trends and competition in different regions. Market share analysis among the market players is analyzed to signify percentage share of the major players operating in the tumor ablation market. Furthermore, the report incorporates market attractiveness analysis by geography that depicts the most attractive and significant region in the global market in 2015.
The research methodology is a combination of primary and secondary research. Primary research includes information collected via e-mails, and telephonic interviews of Key Opinion Leaders (KOL), and forms the bulk of our research. Secondary research includes information collected from various sources, by study of company websites, annual reports, stock analysis presentations, press releases, and various national and international databases.
Global Tumor Ablation Market: Segmentation Based on technology, global tumor ablation market is segmented on the basis of technology are radiofrequency ablation, microwave ablation, Cryoablation, high-intensity focused ultrasound, laser interstitial thermal ablation, and others. Based on disease indication, the tumor ablation market are segmented into liver cancer, lung cancer, kidney cancer, bone cancer, breast cancer, prostate cancer, and others. End users in the tumor ablation market are, hospitals, cancer specialty clinics, and others (long term care center, research, academics, nursing facility, etc.)
Based on geography, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The regions are further segmented into major countries which include, U.S., Canada, Germany, U.K., France, Spain, Italy, Russia, rest of Europe, India, China, Japan, Australia and New Zealand, Rest of Asia Pacific, Brazil, Mexico, Rest of Latin America, GCC countries, South Africa and Rest of Middle East and Africa.
Companies Mentioned in the Report The report also comprises list major players in the market, their SWOT analysis, market share of these players in the tumor ablation, key business strategies, product portfolios, and recent developments. Key market players profiled in this report include, Medtronic plc, Integra LifeSciences Holdings Corporation, BTG International Ltd, Boston Scientific Corporation, AngioDynamics, Inc., SonaCare Medical, LLC., BVM Medical Limited, St. Jude Medical, Inc., and EDAP TMS S.A.
The global tumor ablation market has been segmented as follows: By Technology Radiofrequency Ablation Microwave Ablation Cryoablation High-Intensity Focused Ultrasound Laser Interstitial Thermal Ablation Others
By Material Liver cancer Lung cancer Kidney cancer Bone cancer Breast cancer Prostate cancer Others
By End Users Hospitals Cancer Specialty Clinics Others
By Geography North America U.S. Canada
Europe Germany France U.K. Spain Italy Russia Rest of Europe
Asia Pacific India China Japan Australia & New Zealand Rest of Asia Pacific
Latin America Brazil Mexico Rest of Latin America Middle East and Africa GCC countries South Africa Rest of MEA
Our reports have been used by over 10K customers, including:
Endoscope - Radiofrequency Ablation (RFA) Market by Application (Cardiology, Applications, Pain Management, Oncology Applications, and Other Applications) - Global Opportunity Analysis and Industry Forecast, 2017-2025 Endoscopic RFA is an advanced treatment modality, which is commonly applied in the treatment of medical...
Refractory Anemia Global Clinical Trials Review, H1, 2018 Summary GlobalData’s clinical trial report, “Refractory Anemia Global Clinical Trials Review, H1, 2018" provides an overview of Refractory Anemia clinical trials scenario.This report provides top line data relating to the clinical trials on...
Myelofibrosis Global Clinical Trials Review, H1, 2018 Summary GlobalData’s clinical trial report, “Myelofibrosis Global Clinical Trials Review, H1, 2018" provides an overview of Myelofibrosis clinical trials scenario.This report provides top line data relating to the clinical trials on Myelofibrosis. Report...